Articles

Research safety programs should address not only immediate hazards, but daily laboratory activities that could cause adverse effects down the road.

Alpha thalassemia was once a fatal diagnosis. Now, a clinical trial tests if administering a mother’s stem cells in utero may cure kids before they’re born.

As the antibiotic resistance crisis grows, scientists eye a predatory bacterium as a potential therapeutic.

Mixed messages surrounding their clinical benefits threatened the legitimacy of stem cell therapies for multiple sclerosis, but there is still plenty of promise.

Synthetic biologists are looking into the secrets of the inner ear to treat hearing loss, one of the most common and intractable health concerns in adults worldwide.

A specific blood-brain barrier protein may present a potential target for treatment-resistant epilepsy. 

Researchers identified immune cell imposters that are responsible for immune evasion in pancreatic cancer.

We should work to dispel the myth of the lone genius and embrace collaboration.

Researchers discovered a molecule that halts liver tumor growth when it’s turned on by a sulfotransferase — and evidence that other drugs behave the same way.

Researchers develop gluten-degrading enzymes to administer as drugs or incorporate into food and explore therapies that block downstream disease checkpoints.